Zhengye Biotechnology Holding Limited ZYBT
ZYBT
Zhengye Biotechnology Holding Limited IXHL
Incannex Healthcare Limited SXTC
China SXT Pharmaceuticals, Inc. CTOR
Citius Oncology, Inc. MOLN
Molecular Partners AG RCEL
AVITA Medical, Inc. SPRO
Spero Therapeutics, Inc. MBOT
Microbot Medical Inc. LNSR
LENSAR, Inc. GLSI
Greenwich LifeSciences, Inc.
Zhengye Biotechnology Holding Limited IXHL
Incannex Healthcare Limited SXTC
China SXT Pharmaceuticals, Inc. CTOR
Citius Oncology, Inc. MOLN
Molecular Partners AG RCEL
AVITA Medical, Inc. SPRO
Spero Therapeutics, Inc. MBOT
Microbot Medical Inc. LNSR
LENSAR, Inc. GLSI
Greenwich LifeSciences, Inc.
Performance
| Periode | ZYBT | IXHL | SXTC | CTOR | MOLN | RCEL | SPRO | MBOT | LNSR | GLSI |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -50.61 % | -37.61 % | -14.71 % | 151.83 % | -2.56 % | -42.25 % | 234.50 % | 14.51 % | -14.00 % | 15.42 % |
| YTD | -41.36 % | -81.16 % | -62.82 % | 44.54 % | -21.77 % | -58.33 % | 130.56 % | 156.14 % | 33.60 % | -12.01 % |
| 1Y | -41.36 % | -78.74 % | -71.34 % | 72.00 % | -23.03 % | -48.85 % | 107.50 % | 202.78 % | 124.56 % | -27.05 % |
| 3Y | -41.36 % | -91.04 % | -98.92 % | -84.95 % | -38.85 % | 10.12 % | 24.50 % | -38.27 % | 113.03 % | 5.30 % |
| 5Y | -41.36 % | -97.44 % | -99.97 % | -84.95 % | -80.61 % | -78.29 % | -80.88 % | -63.41 % | 23.51 % | 133.18 % |
| 10Y | -41.36 % | -97.44 % | -100.00 % | -84.95 % | -80.61 % | -39.77 % | -78.35 % | -99.58 % | 29.00 % | 106.60 % |
| Depuis le début | -41.36 % | -97.44 % | -100.00 % | -84.95 % | -80.61 % | -78.68 % | -78.35 % | -100.00 % | 29.00 % | 106.60 % |